ARYx Therapeutics, Inc. (ARYX)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 11, 2025
ARYx Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | 2004 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '10 Sep 30, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | 2004 |
| Net Income | -18.33 | -33.17 | -31.22 | -27.56 | -27.33 | -27.96 | Upgrade
|
| Depreciation & Amortization | 0.95 | 1.08 | 1.1 | 1.01 | 0.83 | 0.56 | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.01 | 0.02 | - | 0.01 | 0.11 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.18 | 0.2 | 0.2 | -0.01 | -0.01 | 0.02 | Upgrade
|
| Stock-Based Compensation | 0.98 | 1.93 | 2.15 | 1.21 | 0.63 | 0.42 | Upgrade
|
| Other Operating Activities | 0.24 | 0.22 | 0.3 | -0.21 | 0.1 | 0.4 | Upgrade
|
| Change in Accounts Payable | -2.06 | -1.7 | 0.85 | 0.96 | 0.09 | -1.2 | Upgrade
|
| Change in Unearned Revenue | - | - | -19.5 | -3.88 | 23.38 | - | Upgrade
|
| Change in Other Net Operating Assets | -2.03 | -3.56 | 0.9 | 0.76 | -2.01 | 5.33 | Upgrade
|
| Operating Cash Flow | -20.07 | -34.97 | -45.22 | -27.71 | -4.21 | -22.43 | Upgrade
|
| Capital Expenditures | -0.05 | -0.14 | -0.64 | -0.5 | -0.96 | -3.85 | Upgrade
|
| Investment in Securities | 7.68 | 8.36 | -1.47 | 24.02 | -17.74 | 13.37 | Upgrade
|
| Other Investing Activities | 0.49 | 0.2 | -0.3 | -0.15 | 0.19 | - | Upgrade
|
| Investing Cash Flow | 8.11 | 8.41 | -2.41 | 23.37 | -18.51 | 9.53 | Upgrade
|
| Long-Term Debt Issued | - | - | 10 | - | 0.68 | 11.18 | Upgrade
|
| Long-Term Debt Repaid | - | -2.99 | -2.3 | -2.9 | -1.97 | -0.09 | Upgrade
|
| Net Debt Issued (Repaid) | 0.82 | -2.99 | 7.7 | -2.9 | -1.29 | 11.09 | Upgrade
|
| Issuance of Common Stock | 7.46 | 1.26 | 20.45 | 44.05 | 0.06 | 0.09 | Upgrade
|
| Other Financing Activities | -0.22 | -0.31 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 8.07 | -2.04 | 28.15 | 41.15 | 28.93 | 11.18 | Upgrade
|
| Net Cash Flow | -3.89 | -28.59 | -19.48 | 36.82 | 6.21 | -1.73 | Upgrade
|
| Free Cash Flow | -20.12 | -35.11 | -45.86 | -28.2 | -5.18 | -26.28 | Upgrade
|
| Free Cash Flow Margin | - | - | -232.52% | -678.31% | -109.20% | - | Upgrade
|
| Free Cash Flow Per Share | -0.65 | -1.28 | -2.42 | -8.43 | -5.08 | -28.88 | Upgrade
|
| Cash Interest Paid | 1.33 | 1.33 | 1.18 | 0.81 | 0.94 | 0.19 | Upgrade
|
| Levered Free Cash Flow | -10.64 | -21.47 | -19.4 | -16.22 | -14.91 | - | Upgrade
|
| Unlevered Free Cash Flow | -9.58 | -20.22 | -18.2 | -15.38 | -14.08 | - | Upgrade
|
| Change in Working Capital | -4.09 | -5.25 | -17.74 | -2.16 | 21.46 | 4.13 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.